Cancer and Leukemia Group B Gastrointestinal Cancer Committee: Table 1.
نویسندگان
چکیده
منابع مشابه
Cancer and leukemia group B gastrointestinal cancer committee.
The Cancer and Leukemia Group B Gastrointestinal Cancer Committee was organized in the late 1970s under the leadership of Michael Perry and Philip Schein and began full-scale operations in the mid-1980s. Today, it is a multidisciplinary team of surgeons, radiation and medical oncologists, statisticians, quality-of-life experts, pharmacogeneticists, basic scientists, and community oncologists wh...
متن کاملCancer and leukemia group B surgery committee.
Surgeons play a vital role in the Cancer and Leukemia Group B by providing patients and specimens for studies of the common solid tumors, and more recently, by serving as investigators who conduct surgically focused research protocols and contribute to the correlative science studies in the Group. Surgical activities encompass thoracic, gastrointestinal, breast, and genitourinary cancers and me...
متن کاملThe cancer and leukemia group B pathology committee at 50.
The Pathology Committee of the Cancer and Leukemia Group B (CALGB) is broadly and deeply integrated into the multidisciplinary clinical and scientific operations of the group. It has five major functions in CALGB. First, it insures the highest possible quality of pathologic data in tissue-based correlative science studies through comprehensive quality control of all tissues collected, banked, a...
متن کاملThe cancer and leukemia group B transplant committee.
The Transplant Committee of the Cancer and Leukemia Group B has a robust portfolio of studies and is poised to make significant contributions to the field. We are working in collaboration with the Cancer and Leukemia Group B Leukemia and Lymphoma Disease Committees and importantly in collaboration with other groups to define the role of both autologous and reduced-intensity allogeneic transplan...
متن کاملThe cancer and leukemia group B respiratory committee.
The Cancer and Leukemia Group B Respiratory Committee has a 30-year track record of clinical investigation in patients with small-cell lung cancer and non-small-cell lung cancer (NSCLC) and mesothelioma. The most widely recognized contributions of the Committee include the early confirmation of the role of concurrent chemoradiotherapy in LD-SCLC, the effect of combination chemotherapy followed ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cancer Research
سال: 2006
ISSN: 1078-0432,1557-3265
DOI: 10.1158/1078-0432.ccr-06-9004